Vanguard Group’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $580M | Sell |
15,761,691
-850,344
| -5% | -$31.3M | 0.01% | 945 |
|
|
2025
Q1 | $587M | Sell |
16,612,035
-484,420
| -3% | -$17.1M | 0.01% | 901 |
|
|
2024
Q4 | $748M | Buy |
17,096,455
+2,185,082
| +15% | +$95.6M | 0.01% | 815 |
|
|
2024
Q3 | $676M | Buy |
14,911,373
+533,076
| +4% | +$24.2M | 0.01% | 863 |
|
|
2024
Q2 | $558M | Sell |
14,378,297
-378,815
| -3% | -$14.7M | 0.01% | 921 |
|
|
2024
Q1 | $476M | Buy |
14,757,112
+122,721
| +0.8% | +$3.96M | 0.01% | 1024 |
|
|
2023
Q4 | $420M | Buy |
14,634,391
+4,990,800
| +52% | +$143M | 0.01% | 1073 |
|
|
2023
Q3 | $267M | Buy |
9,643,591
+303,088
| +3% | +$8.39M | 0.01% | 1282 |
|
|
2023
Q2 | $250M | Buy |
9,340,503
+37,950
| +0.4% | +$1.02M | 0.01% | 1344 |
|
|
2023
Q1 | $201M | Buy |
9,302,553
+1,740,643
| +23% | +$37.7M | 0.01% | 1453 |
|
|
2022
Q4 | $180M | Buy |
7,561,910
+577,908
| +8% | +$13.8M | ﹤0.01% | 1487 |
|
|
2022
Q3 | $138M | Buy |
6,984,002
+1,416,990
| +25% | +$27.9M | ﹤0.01% | 1609 |
|
|
2022
Q2 | $109M | Sell |
5,567,012
-490,919
| -8% | -$9.57M | ﹤0.01% | 1768 |
|
|
2022
Q1 | $155M | Sell |
6,057,931
-241,678
| -4% | -$6.17M | ﹤0.01% | 1710 |
|
|
2021
Q4 | $159M | Buy |
6,299,609
+59,411
| +1% | +$1.5M | ﹤0.01% | 1731 |
|
|
2021
Q3 | $172M | Buy |
6,240,198
+971,634
| +18% | +$26.7M | ﹤0.01% | 1693 |
|
|
2021
Q2 | $167M | Buy |
5,268,564
+418,302
| +9% | +$13.3M | ﹤0.01% | 1729 |
|
|
2021
Q1 | $223M | Buy |
4,850,262
+812,442
| +20% | +$37.3M | 0.01% | 1527 |
|
|
2020
Q4 | $160M | Buy |
4,037,820
+587,719
| +17% | +$23.3M | ﹤0.01% | 1592 |
|
|
2020
Q3 | $120M | Buy |
3,450,101
+2,131,334
| +162% | +$74.2M | ﹤0.01% | 1594 |
|
|
2020
Q2 | $41.6M | Buy |
1,318,767
+229,117
| +21% | +$7.23M | ﹤0.01% | 2092 |
|
|
2020
Q1 | $23.9M | Buy |
+1,089,650
| New | +$23.9M | ﹤0.01% | 2201 |
|